QAIBio aims to reduce the over $400B annual losses due to drugs that fail in the clinical trial value chain. Q-Tool will focus on optimizing the number one reason why drugs fail: toxicity and safety. The Quantum-Enhanced Universal Redesign Algorithm (QUR) represents a significant advancement in drug discovery and repurposing by integrating multiple quantum-enhanced techniques to facilitate the redesign and repurposing of failed drug candidates. Q-Tool leverages quantum computing to explore extensive chemical spaces, optimize molecular structures, and predict drug-target interactions with unprecedented precision. The QUR methodology incorporates Quantum Multidimensional Encoding (QME), Dynamic Quantum Molecular Dynamics (DQMD), Fractional Quantum Spectroscopy (FQS), and Quantum-Classical Adaptive Resonance (QCAR) to address the critical challenges of drug discovery and repurposing.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 515 N State St, Chicago,illinois 60654,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://qaibio.co
- HQ
- Chicago, Illinois
Qaibio Questions
Qaibio's website is https://qaibio.co
Qaibio's LinkedIn profile is https://www.linkedin.com/company/qaibio
Qaibio has
1 employees.
View email and phone details for 1
employees at Qaibio.
Qaibio's industry is
Biotechnology Research
Qaibio's top competitors are
Flutter Social,
You2yourself,
Polotsky,
Ezmems,
Flutter,
Diagnostic Ventures,
Reengage Therapeutics,
Kimera Labs Inc,
Interactome Biotherapeutics,
Quantum Neural Technologies (Qn⊗t) Sa.
Qaibio's categories are Biotechnology Research
Qaibio's founding year is 2024
